| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 144 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 124 |
| 2 | TACROLIMUS OINTMENT 0.1% | 124 |
| 3 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 123 |
| 4 | MYCOPHENOLATE MOFETIL | 122 |
| 5 | PREDNISONE | 58 |
| 6 | CYCLOSPORINE | 56 |
| 7 | FLUDARABINE PHOSPHATE | 53 |
| 8 | CYCLOPHOSPHAMIDE | 42 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 42 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCORTISONE OINTMENT | 1 | 0.0500 |
| 1 | AUTOLOGOUS CULTURED CHONDROCYTES | 5 | 0.0111 |
| 2 | IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS | 1 | 0.0109 |
| 3 | FIBRINOGEN HUMAN | 1 | 0.0043 |
| 4 | THIOTEPA | 31 | 0.0032 |
| 5 | THROMBIN HUMAN AND FIBRINOGEN | 1 | 0.0030 |
| 6 | TREOSULFAN | 8 | 0.0029 |
| 7 | BASILIXIMAB | 33 | 0.0028 |
| 8 | CLEVIDIPINE | 1 | 0.0027 |
| 9 | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 1 | 0.0021 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Autologous Cultured Cell [EPC] | 5 | 0.0111 |
| 1 | Human Blood Coagulation Factor [EPC] | 2 | 0.0024 |
| 2 | CD22-directed Immunoconjugate [EPC] | 3 | 0.0010 |
| 3 | Plasma Volume Expander [EPC] | 3 | 0.0010 |
| 4 | Selective T Cell Costimulation Blocker [EPC] | 4 | 0.0008 |
| 5 | Lipid-based Polyene Antifungal [EPC] | 9 | 0.0007 |
| 6 | Antimetabolite Immunosuppressant [EPC] | 13 | 0.0006 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 13 | 0.0006 |
| 8 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 9 | Actinomycin [EPC] | 1 | 0.0005 |